Skip to content

Cancer Center Amsterdam

Research groups

  • Patient Research Groups (PRGs)
    Patient Research Groups (PRGs) Cancer Center Amsterdam has established Patient Research Groups (PRGs) to embed research, both preclinical and clinical, into patient care.
  • Group of Sarah Derks
    Group of Sarah Derks My research focus is finding better therapies for patients with gastroesophageal cancer (GEA) by studying the biological foundation of the disease. As a physician scientist I use a bedsite-to bench approach and search solutions for clinical problems in the lab.
  • Group of Surgical Upper GI researchers
    Group of Surgical Upper GI researchers Esophageal cancer is a serious condition, with approximately 2,500 people diagnosed each year in the Netherlands. The Upper GI surgical group is dedicated to improving care and treatment for esophago-gastric cancer patients.
  • Clinical Pharmacology and Pharmacy
    Clinical Pharmacology and Pharmacy Our pharmaceutic research focuses on precision medicine, aiming to improve efficacy and reduce toxicity of anticancer drug therapy.
  • Group of Renske Steenbergen
    Group of Renske Steenbergen Infections with high-risk human papillomaviruses (HPVs) are causative events for cervical cancer and subgroups of other anogenital cancers such as anal and vulva cancer.
  • Group of Vera Keil
    Group of Vera Keil Neuro-oncological imaging, the imaging of brain tumors, is a diversified field of research at Amsterdam UMC where several smaller labs work constantly together like the fingers of a hand to get a grip on the disease.
  • Group of Michiel Pegtel
    Group of Michiel Pegtel Tumor-derived extracellular vesicles, including exosomes, are increasingly recognized as key players in cell-cell communication and have been implicated in cancer initiation, invasive behavior, metastatic outgrowth and immunescape.
  • Group of Ronald Boellaard
    Group of Ronald Boellaard The major research area is PET quantification, including the development and evaluation of PET instrumentation, image reconstruction and tracer kinetic modelling.
  • Group of Arnon Kater
    Group of Arnon Kater Professor Arnon Kater's research, particularly in chronic lymphocytic leukemia (CLL), bridges the gap between fundamental scientific discoveries and clinical applications, significantly advancing our understanding and treatment of this complex disease.
  • Group of Elisa Giovannetti
    Group of Elisa Giovannetti The Cancer Pharmacology Lab aims at improving cancer therapeutics either by the development/optimization of new antitumor agents and more effective drug combinations (including chemotherapy, targeted therapy and immunotherapy) as well as by tailoring existing and new therapies.
  • Group of Connie Jimenez
    Group of Connie Jimenez To better understand cancer in all its facets and work towards improved diagnostics and treatment, the OncoProteomics Laboratory (OPL) focuses on the comprehensive analysis of proteins, the functional building blocks of life, whose activities and functions are highly altered in cancer cells.
  • Group of Hanneke van Laarhoven
    Group of Hanneke van Laarhoven Van Laarhoven is a staunch advocate of interdisciplinarity, as is evidenced by her two masters - in Medicine and Theology (both cum laude), as well as her two PhDs - in Medical Oncology (cum laude) and Religious Studies.
  • Group of Marcel Spaargaren
    Group of Marcel Spaargaren Our research is focused on the molecular and cellular aspects of the pathogenesis of (mature) B-cell malignancies, including non-Hodgkin lymphoma, specifically diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), multiple myeloma (MM) and Waldenström's Macroglobulinaemia (WM).
  • Group of Jacqueline Cloos
    Group of Jacqueline Cloos Our work is dedicated to improving diagnostics, treatment strategies and ultimately outcome of acute leukemia patients. We focus on detecting residual leukemia cells that remain after chemotherapy: measurable residual disease (MRD).
  • Group of Juan J. Garcia Vallejo
    Group of Juan J. Garcia Vallejo Two of the most relevant characteristics of the immune system are its highly complex heterogeneity in terms of cell types and functional states, and, the interconnectedness of all these cell subsets.
  • Group of Jacques Bergman
    Group of Jacques Bergman The esophageal research team of the department of Gastroenterology & Hepatology is chaired by Jacques Bergman, MD, PhD, professor of Gastrointestinal Endoscopy and departmental Deputy Chair.
  • Group of Hans Crezee
    Group of Hans Crezee Hyperthermia has pleiotropic effects on tumor cells, our research aims at establishing the optimal temperature, timing and sequence when combining hyperthermia with radiotherapy or chemotherapy.
  • Group of Rosalie Luiten
    Group of Rosalie Luiten The Pigment cell research team at Amsterdam UMC, headed by prof. dr. Rosalie Luiten, is specialized in vitiligo and skin cancer and includes both autoimmunity and cancer immunity research.
  • Group of Linda Douw
    Group of Linda Douw In the multiscale network neuroscience (MULTINET) team we strive to improve glioma patient outcomes by understanding and manipulating personalized multiscale network data.
  • Group of Arjan Griffioen
    Group of Arjan Griffioen The Angiogenesis Laboratory has a long-standing interest in the biology of the tumor vasculature.
  • Group of Victor Thijssen
    Group of Victor Thijssen My group is interested in deciphering the molecular response mechanisms to clinical schedules of fractionated radiotherapy.
  • Group of Maarten Bijlsma
    Group of Maarten Bijlsma Our group aims to understand the tumor biology that explains the poor outcome of upper GI cancers, and ultimately improve the treatment of these diseases. Projects running in the group fall under three major themes.